Turning Around a Breech Baby Nov 10, 2009
By the thirty second week, the vast majority are in the head down, or vertex, position, and between the thirty second and thirty sixth week, most of the rest do down as well ... The preferred position for the baby to be in for delivery is vertex ... In order to avoid a c-section or a potentially complicated delivery, you can try to turn your baby into a vertex position. (Suite101.com)
Vertex pitches hepatitis drug to key doctors Nov 2, 2009
One scheduled for tomorrow will outline studies showing that, in clinical trials, more than 80 percent of hepatitis C patients using a treatment regimen based on Vertex s drug, Telaprevir, achieved a sustained viral response, meaning the drug removed the virus from their bodies. It s a very important opportunity for us to provide our data to the medical community, said Matthew Emmens, who this year became Vertex s chief executive ... This week s presentations by Vertex and rival companies... (Boston Globe)
Vertex loss grows on increased development costs Nov 1, 2009
Vertex Pharmaceuticals Inc. reported a larger third-quarter loss on Monday, as revenue fell and the company spent more money to support the launch of its hepatitis C drug candidate. Vertex posted a loss of $149 ... Most of Vertex's costs held steady during the quarter, but sales, general and administrative spending climbed to $36. (Yahoo News -- Pharmaceutical Industry News)
Vertex drug helps hepatitis C patients Nov 1, 2009
Vertex Pharmaceuticals Inc. said Wednesday its hepatitis C treatment telaprevir created an immune system response to the virus in patients who had not been helped by other drugs ... Vertex said a majority of patients who had had no response to other drugs, or had only a partial response or relapsed after treatment, were free from the virus after being dosed with telaprevir in the study ... Vertex said virus levels were undetectable in 90 percent of the relapsed group and 55 percent of the... (Yahoo News -- Pharmaceutical Industry News)
Vertex Acquires Securities of PRT Forest Regeneration Income Fund Oct 30, 2009
Source: Vertex One Asset Management Inc. ... VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 29, 2009) - The Vertex Managed Value Portfolio announces that it has acquired 1,106,100 units of PRT Forest Regeneration Income Fund ("PRT") representing approximately 11 ... 42% of the issued and outstanding units of PRT and the Vertex Value Fund announces that it has acquired 22,500 units of PRT representing approximately 0. (CCNMatthews Press Releases)
Vertex drug helps hepatitis C patients Oct 29, 2009
Vertex Pharmaceuticals Inc. said Wednesday its hepatitis C treatment telaprevir created an immune system response to the virus in patients who had not been helped by other drugs ... Vertex said a majority of patients who had had no response to other drugs, or had only a partial response or relapsed after treatment, were free from the virus after being dosed with telaprevir in the study ... Vertex said virus levels were undetectable in 90 percent of the relapsed group and 55 percent of the... (Yahoo News -- Pharmaceutical Industry News)
Vertex loss grows on increased development costs Oct 27, 2009
Search Type Choose a search type from the items below. More on Health Care Industry. (Yahoo News -- Pharmaceutical Industry News)
Stacks Of Filter Paper Provide A Realistic, Easy-to-use Medium For Growing Cells Oct 24, 2009
The work was supported by funds from the Wyss Institute, National Institutes of Health, Vertex Inc., DoD Breast Cancer Innovator Award, the Fulbright-Generalitat de Catalunya, and the American Heart Association. In addition to Derda, Whitesides and Ingber, the founding director of the Wyss Institute, a faculty member at Harvard's Medical School and its School of Engineering and Applied Sciences, and a researcher at Children's Hospital Boston, the paper's other authors are: Akiko Mammoto and... (Science Daily)
Mid-tier IT cos on prowl again; look to hire up to 30K Oct 17, 2009
Those on the lookout for trained hands are companies like GlobalLogic India, Aricent, MindTree, CPA Global, Sapient, Symphony Services, Citrix, Adobe, Persistent Solutions, nVidia, Amazon, Agilent and Vertex. Customers are stretching their dollars, and outsourcing helps them do that. (India Times)
The Dollar Kerfuffle Oct 9, 2009
It's top five holdings include Amgen, Gilead Sciences, Celgene, Vertex Pharmaceuticals and Alexion Pharmaceuticals. Its expense ratio is 0. (Human Events Online)
Iron Mountain director uses stock to his advantage Raytheon's Swanson chooses cash option Bruker cashes out Laukiens Oct 2, 2009
Boger, Joshua S $2,563,664 VERTEX PHARMACEUTICALS INC. VRTX ... Smith, Ian F $965,557 VERTEX PHARMACEUTICALS INC VRTX ... Mueller, Peter $438,860 VERTEX PHARMACEUTICALS INC VRTX. (Boston Business Journal, MA)
Alamo work would require mold removal Oct 1, 2009
Another company, Vertex Air Quality Services LLC, which would only remove the mold that can be seen, is asking for $30,000, Clancy said, adding that the town is waiting on two other estimates. Clancy said the ServiceMaster estimate is based on the fact that there is much more mold that needs to be removed besides that which can only be seen. (Marshfield Mariner, MA)
Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells Sep 25, 2009
The two receptors in each dimer twine around one another, and those dimers then cluster together at one vertex of the hexagon to form a trimer. "One beauty of this is that we've shown that the receptors cluster in cells in the same way they did in the crystal structure," says Jensen. (EurekAlert!)
Wood on Words: Latin verb vetere turns into many English words Sep 19, 2009
The aforementioned vertere also was turned into vertex the top or, in Webster s words, properly the turning point. From vertex we get vertical, the position that s perpendicular to the plane of the horizon the horizontal. (Belmont Citizen Herald, MA)
Gene Predicts Response to Hepatitis C Drugs Aug 18, 2009
The drugs are now in mid-stage development by Schering-Plough and Vertex Pharmaceuticals Inc.. Reuters Health. (MEDLINEplus)
Healthy Returns for Pharmaceutical Funds Jul 18, 2009
He's a big holder of Vertex Pharmaceuticals (NasdaqGS: - ), which is in the late stages of testing a drug for Hepatitis C. "The benefit over the current standard of care would be substantial -- and would make Vertex attractive," says Jenner, who has managed the fund since 2000 ... Vertex Pharmaceuticals. (Yahoo News -- Pharmaceutical Industry News)
Children's in cystic fibrosis trial test Jun 26, 2009
The Cystic Fibrosis Center at the hospital is the first site to begin recruiting patients for the 48-week international clinical trial to test the VX-770 drug developed by Vertex Pharmaceuticals Inc. of Cambridge, Mass ... Vertex will conduct three different clinical trials as part of the registration program for the drug involving approximately 110 sites ... Vertex retains worldwide rights to develop and commercialize the drug, if it gains regulatory approval. (Buffalo Business First, NY)
Families of Spinal Muscular Atrophy Announces Latest Developments on Three SMA Drug Discovery Programs Jun 19, 2009
This is the program previously worked on by Vertex Pharmaceuticals and deCODE genetics, and fully funded by Families of SMA.. The next step for this program is to request a pre-IND meeting with the FDA and to prepare the required data package. (PR Newswire)
Medtronics payment to DePuy reduced Jun 3, 2009
The Vertex line of screws is no longer on the market. Memphis-based Medtronic Spinal and Biologics business president Steve La Neve said the ruling has no bearing on our current Vertex Select and OC Systems, which are other spinal systems. (Memphis Business Journal, TN)
Verdict gives Medtronic a break Jun 3, 2009
The lawsuit was filed by DePuy Spine over a line of Medtronic spinal products dubbed Vertex. Medtronic, which makes medical devices, said Tuesday an appeals court has reduced the amount of damages it must pay by more than $87 million. (Twin Cities Business Journal, MN)
ChemGenex Says Drug Rids Leukemia From Blood in 85% of Patients in Trials Jun 2, 2009
Merck & Co. stopped recruiting patients for trials of a similar product developed with Vertex Pharmaceuticals Inc. in 2007 because of adverse reactions. Gleevec, also sold as Glivec, earned Basel, Switzerland- based Novartis last year, according to Bloomberg data. (Bloomberg -- Australia & New Zealand)
Senate hits backat Patrick on ethics May 13, 2009
The Seventy-First Fund has collected contributions from prominent executives and entrepreneurs, including Cleve Killingsworth, chief executive of Blue Cross/Blue Shield; former Citizens Financial Group chairman Lawrence Fish; and Joshua Boger, chief executive of Vertex Pharmaceuticals. Patriots owner Robert Kraft donated $5,500 to the fund in December, just after the administration designated 500 acres near Foxboro Stadium as a growth district, making it eligible for fast-track approvals and... (Boston Globe)
Hepatitis C: Added Anti-viral Improves Response, Halves Duration Of Treatment, Study Suggests May 7, 2009
The study was funded by Vertex Pharmaceuticals, the maker of the drug telaprevir, a protease inhibitor that works by blocking an enzyme that the hepatitis C virus needs in order to replicate itself ... Other researchers involved in this study include Gregory Everson of the University of Colorado Health Science Center; Stuart Gordon of Henry Ford Hospital; Ira Jacobson of Weill Cornell Medical College; Mark Sulkowski of Johns Hopkins School of Medicine; and Robert Kauffman, Lindsay McNair and... (Science Daily)
Medtronic launches two new spinal products May 6, 2009
The Vertex Select Reconstruction System Occipitocervical Module is used when spinal conditions require the base of the skull to be fused to the neck. Vertex is an implant system and an instrument set for the procedure. (Memphis Business Journal, TN)
Full swine flu coverage Apr 30, 2009
The findings also suggest the drug telaprevir, made by Vertex Pharmaceuticals Inc., which sponsored the two studies, can cut treatment time from one year to six months. However, those taking the drug reported more side effects including severe rash, nausea and anemia than those on standard treatment alone. (San Diego Union-Tribune)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Infection Apr 30, 2009
From the Duke Clinical Research Institute and Duke University, Durham, NC (J.G.M., A.J.M.); the Division of Gastroenterology and Hepatology, University of Colorado Health Science Center, Denver (G.T.E.); Division of Hepatology, Henry Ford Hospital, Detroit (S.C.G.); Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York (I.M.J.); Johns Hopkins University, Baltimore (M.S.); and Vertex Pharmaceuticals, Cambridge, MA (R.K., L.M., J.A.). Address reprint requests to Dr.... (New England Journal of Medicine)
Drug shows promise against hepatitis C Apr 30, 2009
The findings also suggest the drug telaprevir, made by Vertex Pharmaceuticals Inc., which sponsored the two studies, can cut treatment time from one year to six months ... "We can now sit down with our patients and tell them that 2 of 3 patients can be cured with a 24-week course of therapy," said Dr. John McHutchison, a Duke University doctor who led one study and has consulted for Vertex, based in Cambridge, Mass. (MSNBC -- Health)
Danvers firm wins recognition Apr 28, 2009
A top-ranked construction management firm by such leading publications as ENR and Building Design & Construction, Berry has an impressive portfolio of institutional and corporate clients throughout New England, including Brigham and Women s Hospital, Dartmouth College, Harvard Medical School, Massachusetts Institute of Technology, and Vertex Pharmaceuticals, among others. For more information about William A. Berry & Son, Inc., visit the company s web site at www. (Danvers Herald, MA)
Mass. life-sciences firms expanding, hiring despite credit crunch Apr 14, 2009
And some, like Vertex, have been able to continue to raise money because they are relatively close to winning federal approval for drugs with enormous potential. A number of firms are holding steady. (Boston Globe)
Researchers seek drugs that can fix errant proteins Apr 13, 2009
"For a long time, people felt it was impossible; people had a preconceived notion that it was unlikely a small molecule could actually fix a broken protein. . . . But it turns out that may not be the case," said Paul Negulescu, vice president of research at Vertex is targeting errant, misfolded proteins in cystic fibrosis and Huntington's, and has just began a trial of the effectiveness of its cystic fibrosis drug. "The whole protein-folding pathway has become an area of increased interest,"... (Boston Globe)
A Man with Fever, Headache, Rash, and Vomiting Apr 9, 2009
C, chills, diaphoresis, a throbbing frontal headache that radiated to the vertex, a sore throat, swollen cervical lymph nodes, a cough productive of. . (New England Journal of Medicine)
Biotech CEO: Firms that adapt will thrive Apr 8, 2009
Boger, keynote speaker for the annual event, launched Vertex in 1989 ... He recently spoke to the Charlotte Business Journal about Vertex, his upcoming visit to Charlotte and the challenges facing the biotech sector. (Charlotte Business Journal, NC)
BioMed Realty Trust Receives LEED(R) Gold Certification at Center for Life Science | Boston Apr 3, 2009
In addition, BioMed is in the process of obtaining LEED(R) certification for its 675 West Kendall Street building in Cambridge, Massachusetts which is 100% leased to Vertex Pharmaceuticals, and is targeting Gold LEED(R) certification. Kent Griffin, BioMed's President and Chief Financial Officer, remarked, "With Gold certification for the Center for Life Science | Boston, we now have more than 1.2 million square feet of LEED(R)-certified laboratory and office space in the Cambridge/Boston market.... (PR Newswire)
Gilead Sciences: High-Performing Pharmaceutical Mar 28, 2009
Says Martin: "Like HIV, hep C will require a combination therapy. We need to develop multiple products and have a combination pill to treat this disease." Gilead faces competition from a number of companies in this arena, including Vertex (), a rising biotech star, and Schering-Plough (), which is being acquired by industry powerhouse Merck (). But that may not harm Gilead's prospects in the long run, says Jason Kantor, an analyst with RBC Capital Markets (). (BusinessWeek)
Battle Signs: Merck And J&J? Mar 11, 2009
The Merck-Schering-Plough merger could also impact Vertex Pharmaceuticals (nasdaq: - - ), which is developing a new drug with Johnson on to treat hepatitis C, according to Brian Abrahams, a biotechnology analyst at Oppenheimer /p. Vertex has been racing Schering to bring a new hepatitis C treatment to market ... So far, Vertex appears to be closer to market with a more effective drug. (Forbes -- Business)
Police log: March 3 - 8 Mar 10, 2009
3:07 p.m.- Larceny/forgery/fraud at Vertex Company on Revere Street. Report to be filed. (Canton Journal, MA)
Health & Medicine Feb 28, 2009
Investor's Business Daily: Vertex Exec Change May Be One Of Many ... Vertex Exec Change May Be One Of Many ... Chemist Joshua Boger founded Vertex Pharmaceuticals () 20 years ago. (Investors Business Daily)
Vertex Exec Change May Be One Of Many Feb 28, 2009
Chemist Joshua Boger founded Vertex Pharmaceuticals () 20 years ago ... Vertex has a potential blockbuster drug close to market, and Wall Street has noticed ... He'll hand over the reins to Matthew Emmens, who took over as Vertex president last month. (Investors Business Daily)
Venture capital watch Feb 21, 2009
Intel Capital in Santa Clara invested in three companies based in the United Arab Emirates - Conservus International, which does digital advertising, Pulse Technologies, which makes building automation systems, and Vertex Animation Studio, which provides services for virtual reality applications and 3-D multiplatform games. Source: Dow Jones VentureWire. (San Francisco Chronicle -- Technology)
Universal Energy Group Releases First Quarter Financial Results and Operational Updates Feb 12, 2009
For a reconciliation of Operational Revenue to revenue and Operational Margin to gross margin, see "Reconciliation of Operational Revenue, Operational Margin and Operational Income" in this MD&A. For a discussion of GEM's revenue recognition policies see "Critical Accounting Estimates'' in this MD&A. UNIVERSAL ENERGY GROUP LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS February 12, 2008 Selected Financial Highlights and Overall Performance of the... (CCNMatthews Press Releases)
